Sort
35,931 grants matching “parkinsons”
A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB)
$1,792,741Charbel Moussa · Georgetown University · R01 · FY2021 · AG
IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)
$1,791,614Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2024 · AG
Circuit-based deep brain stimulation for Parkinson's disease
$1,791,322Jerrold L Vitek · University Of Minnesota · P50 · FY2020 · NS
Metabolic Control Analysis
$1,790,340Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA
Molecular Pathogenesis of Age-Dependent CNS Degeneration
$1,789,472Stanley B Prusiner · University Of California, San Francisco · P01 · FY2008 · AG
MICHIGAN ALZHEIMERS DISEASE RESEARCH CENTER
$1,787,637University Of Michigan At Ann Arbor · P50 · FY2003 · AG
Neuroimaging of Brain Circuits and Molecular Mechanisms in Normal Cognition
$1,785,922Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2016 · MH
Human Energy and Body Weight Regulation Core
$1,785,295Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2025 · DK
Distributional reinforcement learning in the brain.
$1,784,522Naoshige Uchida · Harvard University · R01 · FY2020 · NS
Blood-Brain Barrier Permeable Multimodal Imaging Agents for Neurodegenerative Diseases
$1,783,700Liviu M Mirica · University Of Illinois At Urbana-Champaign · RF1 · FY2023 · AG
Laboratory of Neuro Imaging Resource (LONIR)
$1,781,980Arthur W Toga · University Of California Los Angeles · P41 · FY2012 · EB
Biomarkers of Parkinson Disease and Related Disorders
$1,781,723David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,776,884Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2006 · NS
CONNECT-TBI
$1,776,667Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2022 · NS
La Jolla-Parkinson's Disease Center Grant
$1,770,379Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · ES
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,770,369Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2007 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE
$1,770,218Johns Hopkins University · P50 · FY2001 · NS
GENERAL CLINICAL RESEARCH CENTER
$1,767,438University Of Rochester · M01 · FY2000 · RR
Biomarkers of Parkinson Disease and Related Disorders
$1,766,236David Goldstein · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration
$1,765,394Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2022 · DA
CONNECT-TBI
$1,764,251Douglas Hamilton Smith · University Of Pennsylvania · U54 · FY2023 · NS
Indiana Alzheimer Disease Center
$1,763,493Bernardino Ghetti · Indiana University Indianapolis · P30 · FY2011 · AG
RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies
$1,762,299Myriam Gorospe · National Institute On Aging · ZIA · FY2021 · AG
Single-nuclei multiomic analysis of DLB progression
$1,760,872Yoon-Seong Kim · Rutgers Biomedical And Health Sciences · RF1 · FY2022 · NS
Medicinal Chemistry Core
$1,759,916Robert H Mach · University Of Pennsylvania · U19 · FY2020 · NS